Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 159750, 8 pages
http://dx.doi.org/10.1155/2015/159750
Research Article

Tissue Kallikrein Activity, Detected by a Novel Method, May Be a Predictor of Recurrent Stroke: A Case-Control Study

1Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue No. 1095, Wuhan 430030, China
2Department of Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue No. 1095, Wuhan 430030, China
3The Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue No. 1095, Wuhan 430030, China

Received 3 June 2015; Revised 24 August 2015; Accepted 30 August 2015

Academic Editor: Claudio Letizia

Copyright © 2015 Xiao Ran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Johnston, S. Mendis, and C. D. Mathers, “Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling,” The Lancet Neurology, vol. 8, no. 4, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sidney, W. D. Rosamond, V. J. Howard, and R. V. Luepker, “The ‘heart disease and stroke statistics—2013 update’ and the need for a national cardiovascular surveillance system,” Circulation, vol. 127, no. 1, pp. 21–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Xu, X. Liu, W. Wu, R. Zhang, and Q. Yin, “Recurrence after ischemic stroke in chinese patients: impact of uncontrolled modifiable risk factors,” Cerebrovascular Diseases, vol. 23, no. 2-3, pp. 117–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Liu, D. Wang, K. S. L. Wong, and Y. Wang, “Stroke and stroke care in China: huge burden, significant workload, and a national priority,” Stroke, vol. 42, no. 12, pp. 3651–3654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Kim, H.-W. Nah, S. M. Park et al., “Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease,” Stroke, vol. 43, no. 12, pp. 3313–3318, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Golias, A. Charalabopoulos, D. Stagikas, K. A. Charalabopoulos, and A. Batistatou, “The kinin system—bradykinin: biological effects and clinical implications. Multiple role of the kinin system—bradykinin,” Hippokratia, vol. 11, no. 3, pp. 124–128, 2007. View at Google Scholar · View at Scopus
  7. N. Emami and E. P. Diamandis, “Human tissue kallikreins: a road under construction,” Clinica Chimica Acta, vol. 381, no. 1, pp. 78–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Mahabeer and K. D. Bhoola, “Kallikrein and kinin receptor genes,” Pharmacology & Therapeutics, vol. 88, no. 1, pp. 77–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Chao, B. Shen, L. Gao, C.-F. Xia, G. Bledsoe, and L. Chao, “Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing,” Biological Chemistry, vol. 391, no. 4, pp. 345–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Li, T. Kondo, Y. Numaguchi et al., “Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis,” Hypertension, vol. 51, no. 2, pp. 252–258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Westermann, H.-P. Schultheiss, and C. Tschöpe, “New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration,” International Immunopharmacology, vol. 8, no. 2, pp. 148–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Potier, L. Waeckel, C. Richer, R. Roussel, N. Bouby, and F. Alhenc-Gelas, “Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency,” Biological Chemistry, vol. 394, no. 3, pp. 329–333, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Y. Yao, H. Yin, B. Shen, L. Chao, and J. Chao, “Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction,” Journal of Cardiac Failure, vol. 13, no. 7, pp. 588–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R.-Y. Lu, D.-F. Luo, S.-H. Xiao et al., “Kallikrein gene transfer induces angiogenesis and further improves regional cerebral blood flow in the early period after cerebral ischemia/reperfusion in rats,” CNS Neuroscience & Therapeutics, vol. 18, no. 5, pp. 395–399, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-Z. Yu, L.-D. Xie, P.-L. Zhu, C.-S. Xu, and H.-J. Wang, “Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1,” Molecular and Cellular Biochemistry, vol. 360, no. 1-2, pp. 363–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yin, L. Chao, and J. Chao, “Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 8022–8030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Wang, X. Han, M. Cui, K. Fang, Z. Lu, and Q. Dong, “Tissue kallikrein protects rat hippocampal CA1 neurons against cerebral ischemia/reperfusion-induced injury through the B2R-Raf-MEK1/2-ERK1/2 pathway,” Journal of Neuroscience Research, vol. 92, no. 5, pp. 651–657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Yao, Z. Sheng, Y. Li et al., “Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis,” Laboratory Investigation, vol. 93, no. 5, pp. 577–591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ura, K. Shimamoto, T. Nakao et al., “The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension,” Clinical and Experimental Hypertension A, vol. 5, no. 3, pp. 329–337, 1983. View at Publisher · View at Google Scholar · View at Scopus
  20. W. J. Lawton and A. E. Fitz, “Urinary kallikrein in normal renin essential hypertension,” Circulation, vol. 56, no. 5, pp. 856–859, 1977. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Zhang, H. Ding, J. Yan et al., “Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case-control study in China,” Annals of Neurology, vol. 70, no. 2, pp. 265–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Zhang, X. Ran, and D. W. Wang, “Relation of plasma tissue kallikrein levels to presence and severity of coronary artery disease in a Chinese population,” PLoS ONE, vol. 9, no. 3, Article ID e91780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Nikai, Y. Komori, S. Kato, and H. Sugihara, “Biological properties of kinin-releasing enzyme from Trimeresurus okinavensis (himehabu) venom,” Journal of Natural Toxins, vol. 7, no. 1, pp. 23–35, 1998. View at Google Scholar · View at Scopus
  24. A. O. Aasen, W. Frolich, O. D. Saugstad, and E. Amundsen, “Plasma kallikrein activity and prekallikrein levels during endotoxin shock in dogs,” European Surgical Research, vol. 10, no. 1, pp. 50–62, 1978. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Roberts, “Measurement of the rate of plasmin action on synthetic substrates,” The Journal of Biological Chemistry, vol. 232, no. 1, pp. 285–291, 1958. View at Google Scholar
  26. J. M. Da Costa Castro, F. Deschamps, M. Benbachir, J. Henrichsen, P. J. Volle, and R. M. F. Guinet, “Highly sensitive biotin-avidin sandwich ELISA for the rapid detection of pneumococcal capsular polysaccharide antigens,” Journal of Immunological Methods, vol. 104, no. 1-2, pp. 265–270, 1987. View at Publisher · View at Google Scholar · View at Scopus
  27. O. A. Carretero, N. B. Oza, A. Piwonska, T. Ocholik, and A. G. Scicli, “Measurement of urinary kallikrein activity by kinin radioimmunoassay,” Biochemical Pharmacology, vol. 25, no. 20, pp. 2265–2270, 1976. View at Publisher · View at Google Scholar · View at Scopus
  28. S. H. Zinner, H. S. Margolius, B. Rosner, and E. H. Kass, “Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up,” Circulation, vol. 58, no. 5, pp. 908–915, 1978. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Chao, L. Chao, D. M. Tillman, C. M. Woodley, and H. S. Margolius, “Characterization of monoclonal and polyclonal antibodies to human tissue kallikrein,” Hypertension, vol. 7, no. 6, part 1, pp. 931–937, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Chao and L. Chao, “Experimental therapy with tissue kallikrein against cerebral ischemia,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1323–1327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-F. Xia, H. Yin, C. V. Borlongan, L. Chao, and J. Chao, “Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis,” Hypertension, vol. 43, no. 2, pp. 452–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Yuan, J. Deng, T. Wang et al., “Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5′-monophosphate-activated protein kinase signaling pathways,” Endocrinology, vol. 148, no. 5, pp. 2016–2026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. G. S. Ceravolo, A. C. Montezano, M. T. Jordão et al., “An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies,” PLoS ONE, vol. 9, no. 11, Article ID e111117, 2014. View at Publisher · View at Google Scholar
  34. A. Martinsen, N. Baeyens, X. Yerna, and N. Morel, “Rho kinase regulation of vasopressin-induced calcium entry in vascular smooth muscle cell: comparison between rat isolated aorta and cultured aortic cells,” Cell Calcium, vol. 52, no. 6, pp. 413–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Baccarelli, R. Wright, V. Bollati et al., “Ischemic heart disease and stroke in relation to blood DNA methylation,” Epidemiology, vol. 21, no. 6, pp. 819–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. I. A. Qureshi and M. F. Mehler, “Emerging role of epigenetics in stroke—part 1: DNA methylation and chromatin modifications,” Archives of Neurology, vol. 67, no. 11, pp. 1316–1322, 2010. View at Publisher · View at Google Scholar · View at Scopus